Lucerne, Switzerland

Mark Suter



 

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 110(Granted Patents)


Location History:

  • Luzern, CH (2006 - 2013)
  • Lucerne, CH (2003 - 2017)

Company Filing History:


Years Active: 2003-2017

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Mark Suter: Innovator in Immunology

Introduction

Mark Suter is a prominent inventor based in Lucerne, Switzerland. He has made significant contributions to the field of immunology, particularly in developing vaccines for vulnerable populations such as neonates and infants. With a total of 8 patents to his name, Suter's work is recognized for its potential impact on public health.

Latest Patents

Suter's latest patents include groundbreaking inventions aimed at enhancing immune responses in young children. One notable patent is titled "Single high dose of MVA induces a protective immune response in neonates and infants." This invention focuses on compositions and methods for inducing a protective immune response against poxvirus in human neonates or infants under six months of age. The method involves administering a single high dose of Modified Vaccinia Ankara (MVA) to elicit protective T- and B-cell responses.

Another significant patent is "Vaccinia virus mutants containing the major genomic deletions of MVA." This invention provides modified vaccinia virus (VACV) genomes and vectors, including methods for assessing the effects of mutations in VACV regarding replication competence in specific cell types. These innovations are crucial for advancing vaccine development and improving health outcomes for infants.

Career Highlights

Throughout his career, Mark Suter has worked with various organizations, including Bavarian Nordic A/S. His expertise in immunology and vaccine development has positioned him as a key figure in the field. His contributions have not only advanced scientific knowledge but also have the potential to save lives.

Collaborations

Suter has collaborated with notable professionals in the field, including Paul Chaplin and Sabine Vollstedt. These partnerships have facilitated the exchange of ideas and fostered innovation in vaccine research.

Conclusion

Mark Suter's work exemplifies the importance of innovation in immunology, particularly for vulnerable populations. His patents reflect a commitment to enhancing public health through scientific advancement. The impact of his inventions will likely resonate in the field of vaccine development for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…